• In recent months, AXT, Inc. disclosed insider stock sale plans via multiple Form 144 filings and completed a large underwritten public offering, while also holding an adjourned 2026 annual meeting due to lack of quorum.
• At the same time, the company outlined plans to expand indium phosphide production capacity in stages through 2027 by repurposing existing facilities, leaning on its vertically integrated supply chain to address AI and optical networking demand.
• Next, we’ll examine how AXT’s decision to rapidly expand indium phosphide capacity could influence its existing investment narrative and risk profile.

Find 47 companies with promising cash flow potential yet trading below their fair value.

AXT Investment Narrative Recap

To own AXT today, you have to believe its push into indium phosphide can eventually support profitable growth, even as export permits, customer concentration, and weak margins remain central issues. The latest insider Form 144 filings, the adjourned 2026 annual meeting, and the large US$550.0 million equity raise do not materially change the near term capacity ramp as the key catalyst, nor the risk that execution and geopolitical frictions constrain returns from that expansion.

The most relevant announcement here is AXT’s plan to double indium phosphide capacity by the end of 2026 and again in 2027 using repurposed facilities. That choice ties directly into the current AI and optical networking cycle, reinforcing the capacity ramp as the primary story investors are watching, while the size of the recent equity raise underscores how much capital the market is already willing to commit to that thesis.

Yet while the growth story sounds appealing, investors should be aware that export permit uncertainty could still...

AXT's narrative projects $238.5 million revenue and $62.6 million earnings by 2029. This requires 39.3% yearly revenue growth and an earnings increase of about $84 million from -$21.4 million today.

Uncover how AXT's forecasts yield a $30.75 fair value, a 71% downside to its current price.

Exploring Other Perspectives

Some of the most optimistic analysts were already penciling in US$301.5 million of 2029 revenue and US$129.0 million of earnings, yet this new capacity push and ongoing export and customer risks could lead you to reassess whether that upbeat path still feels realistic or too aggressive once all the fresh information is considered.

Explore 5 other fair value estimates on AXT - why the stock might be worth over 2x more than the current price!

Decide For Yourself

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your AXT research is our analysis highlighting 2 key rewards and 3 important warning signs that could impact your investment decision.
• Our free AXT research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate AXT's overall financial health at a glance.

Seeking Other Investments?

Our top stock finds are flying under the radar-for now. Get in early:

• AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• The latest GPUs need a type of rare earth metal called Terbium and there are only 29 companies in the world exploring or producing it. Find the list for free.
• Uncover the next big thing with 24 elite penny stocks that balance risk and reward.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.